Wednesday, Sep 3, 2003
South San Francisco, Calif. -- September 3, 2003 --Genentech, Inc. (NYSE: DNA) announced today the promotion of Richard Scheller, Ph.D., to executive vice president of Research.
In his position, Scheller, 49, is responsible for setting strategy for Genentech's research and drug discovery activities and leads the company's Research organization of approximately 500 researchers. Scheller chairs Genentech's Research Review Committee and is a member of the company's Executive Committee.
"This promotion is a reflection of Richard's significant contributions to Genentech," said Arthur D. Levinson, Ph.D., Genentech's chairman and chief executive officer. "His leadership and scientific expertise has been critical to Genentech in terms of recruiting exciting new research talent and ensuring that the Research organization is well positioned to deliver new scientific discoveries that address significant unmet medical needs."
Scheller, a renowned cell and molecular biologist, joined Genentech in 2001 as senior vice president of Research.
Prior to joining Genentech, Scheller served as professor of Molecular and Cellular Physiology and of Biological Sciences at Stanford University. He also was an investigator with the Howard Hughes Medical Institute, which appoints leading biomedical scientists to prestigious research positions based on their potential to make significant contributions to science.
Scheller's work has earned him numerous awards including the 1997 National Academy of Sciences Award in Molecular Biology. He is a member of the Academy of Arts and Sciences and the National Academy of Sciences. Scheller has served on numerous advisory boards including the National Advisory Mental Health Council of the National Institutes of Health. He has published more than 200 papers in peer-reviewed scientific journals.
Scheller holds a doctorate in chemistry from the California Institute of Technology where he was also a postdoctoral fellow, Division of Biology. He was also a postdoctoral fellow at Columbia University, College of Physicians & Surgeons. He received his bachelor's degree in biochemistry at the University of Wisconsin, Madison.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Sixteen of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes 11 biotechnology products in the United States. The company has headquarters in South San Francisco, California and is traded on the New York Stock Exchange under the symbol DNA. For additional information about the company, please visit www.gene.com